Euglycemic diabetic ketoacidosis in type 2 diabetes with sodium glucose cotransporter 2 inhibitors

Wataru Ogawa, Kazuhiko Sakaguchi, Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors Journal of Diabetes Investigation. ,vol. 7, pp. 135- 138 ,(2016) , 10.1111/JDI.12401

Shivani Misra, Nick S Oliver, Diabetic ketoacidosis in adults BMJ. ,vol. 351, pp. h5660- ,(2015) , 10.1136/BMJ.H5660

Jamie C. Diner, Irl B. Hirsch, Anne L. Peters, Elizabeth O. Buschur, John B. Buse, Pejman Cohan, Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition Diabetes Care. ,vol. 38, pp. 1687- 1693 ,(2015) , 10.2337/DC15-0843

AwadheshKumar Singh, Sodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight Indian Journal of Endocrinology and Metabolism. ,vol. 19, pp. 722- 730 ,(2015) , 10.4103/2230-8210.167554

Saad Syed, Sucheta Gosavi, Waseem Shami, Marco Bustamante, Zul Farah, Muhammad Teleb, Aamer Abbas, Sarmad Said, Debabrata Mukherjee, A Review of Sodium Glucose Co-transporter 2 Inhibitors Canagliflozin, Dapagliflozin and Empagliflozin Cardiovascular and Hematological Agents in Medicinal Chemistry. ,vol. 13, pp. 105- 112 ,(2015) , 10.2174/1871525714666151106121215

Jean-Daniel Lalau, Lactic Acidosis Induced by Metformin Drug Safety. ,vol. 33, pp. 727- 740 ,(2010) , 10.2165/11536790-000000000-00000